Driving the Innovation Engine: Identifying the Eylea Market Key Manufacturers and Their Strategic Research and Development Priorities
  The Eylea market is fundamentally a duopoly, dominated by its originator and licensor, Regeneron Pharmaceuticals, and its exclusive ex-U.S. partner, Bayer AG, making them the definitive Eylea Market Key Manufacturers. Regeneron is responsible for the drug’s discovery, development, and commercialization in the highly lucrative U.S. market, while Bayer holds the exclusive marketing...
0 Kommentare 0 Anteile 0 Vorschau